Please check your internet connection and try again.
## Sompraz hp
**Overview:** Sompraz hp is a combination medication containing lansoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*).
**Primary Indications:** Treatment of *H. pylori* infection in patients with duodenal ulcer disease.
**Adult Dosing:**
* **Sompraz hp:** One capsule (containing lansoprazole 30 mg, amoxicillin 500 mg, and clarithromycin 250 mg) twice daily for 14 days.
* **Administration:** Take one capsule in the morning and one capsule in the evening, typically before a meal.
**Pediatric Dosing:** Not established. Dosing for pediatric patients should be determined by a specialist and based on individual patient factors.
**Dose Adjustments:**
* **Renal Impairment:** Amoxicillin and clarithromycin doses may require adjustment in severe renal impairment. Lansoprazole does not typically require dose adjustment. Consult specific product labeling for guidance.
* **Hepatic Impairment:** Clarithromycin dose may require reduction in hepatic impairment. Consult specific product labeling for guidance.
**Contraindications:**
* Hypersensitivity to lansoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of hypersensitivity to penicillins or cephalosporins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with ergotamine or dihydroergotamine.
* Patients with a known history of QT prolongation, cardiac arrhythmias, or significant electrolyte disturbances.
**Adverse Effects:**
* **Common:** Diarrhea, nausea, vomiting, abdominal pain, taste perversion, headache, rash.
* **Serious:** *Clostridioides difficile*-associated diarrhea, severe allergic reactions (anaphylaxis), *Stevens-Johnson* syndrome, toxic epidermal necrolysis, hepatotoxicity, QT prolongation, *C. pylori* resistance.
**Key Drug Interactions:**
* **Lansoprazole:** May decrease the absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, certain protease inhibitors). May increase the serum concentration of certain drugs (e.g., warfarin, methotrexate, digoxin).
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may decrease renal excretion of amoxicillin.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Increases serum concentrations of numerous drugs including statins (risk of myopathy/rhabdomyolysis), colchicine, azole antifungals, carbamazepine, cyclosporine, digoxin, HIV protease inhibitors, oral anticoagulants, phosphodiesterase inhibitors, quinidine, sirolimus, tacrolimus, theophylline, and triazolobenzodiazepines. Avoid concomitant use with colchicine in patients with renal or hepatic impairment.
**Monitoring:**
* Signs and symptoms of *H. pylori* eradication.
* Signs and symptoms of hypersensitivity reactions.
* Liver function tests, especially with prolonged use or in patients with hepatic impairment.
* Renal function tests in patients with renal impairment.
* Monitor for diarrhea; rule out *C. difficile*-associated diarrhea.
* Electrolyte balance in patients at risk for QT prolongation.
**Clinical Pearls:**
* This combination is designed for a specific duration of therapy. Incomplete treatment can lead to treatment failure and development of antibiotic resistance.
* Ensure patients complete the full course of therapy, even if symptoms improve.
* Educate patients on potential side effects, particularly diarrhea and taste disturbances.
* Consider alternative regimens for patients with penicillin allergy.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete details and to verify dosages and safety information before making any clinical decisions.*
